You are here

Takeda

After epilepsy setback, Ovid charges confidently ahead in CNS

Pharma Voice

Fri, 09/20/24 - 10:27 am

Ovid Therapeutics

US allows increased production of Takeda's ADHD drug to address shortage

Reuters

Wed, 09/4/24 - 11:35 am

With a new oncology head, Takeda revamps its R&D strategy

Pharma Voice

Tue, 08/27/24 - 10:54 am

Lundbeck leaves Trintellix to partner Takeda in the US, opting for royalties as it focuses efforts on Rexulti

Fierce Pharma

Wed, 07/31/24 - 11:16 pm

antidepressants

Takeda takes $140M charge on failed epilepsy drug, while touting continued FDA potential

Fierce Biotech

Wed, 07/31/24 - 10:53 am

Takeda spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants

Fierce Biotech

Tue, 07/9/24 - 11:21 am

clinical trials

Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster

Fierce Biotech

Mon, 07/8/24 - 11:54 am

Takeda to cut another 220 jobs in Massachusetts, while Merck KGaA plots its own layoffs

Fierce Pharma

Tue, 07/2/24 - 11:12 am

Takeda reports positive data from Phase IIb trial of ITP treatment

Clinical Trials Arena

Mon, 06/24/24 - 11:18 am

clinical trials. dengvaxia

Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India

Reuters

Fri, 06/21/24 - 11:02 am

Takeda flunks pivotal epilepsy tests but mulls path to market for Ovid-partnered prospect

Fierce Biotech

Mon, 06/17/24 - 11:29 am

clinical trials

Ovid Therapeutics

Dravet syndrome

Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage

Fierce Pharma

Fri, 06/14/24 - 11:40 am

Ascentage Pharma

The 6 largest biopharma layoffs of 2024 so far

BioSpace

Wed, 06/12/24 - 11:59 am

Bristol Myers Squibb

Behind Big Pharma’s layoffs — is there an end in sight?

Pharma Voice

Tue, 06/11/24 - 11:22 am

Bristol Myers Squibb

Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS

Clinical Trials Arena

Mon, 06/3/24 - 10:31 pm

clinical trials

Hodgkin's lymphoma

After two Big Pharma deals, Nimbus looks to keep the hits coming

Pharma Voice

Mon, 06/3/24 - 12:01 pm

Nimbus Therapeutics

Gilead Sciences

ASCO: GSK builds case for return of multiple myeloma drug Blenrep

BioPharma Dive

Sun, 06/2/24 - 02:45 pm

mutliple myeloma

Takeda, amid restructuring campaign, plots 641 layoffs at two Massachusetts sites

Fierce Pharma

Tue, 05/28/24 - 10:28 pm

Takeda joins hot molecular glue market with $1.2B deal

BioSpace

Thu, 05/23/24 - 11:59 am

Degron Therapeutics

Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot

Pharmaphorum

Mon, 05/13/24 - 11:13 am

Alzheimer's disease

Pages